Abstract
Many neurodegenerative diseases are characterized by amyloid deposition. In Alzheimer's disease (AD), β-amyloid (Aβ) peptides accumulate extracellularly in senile plaques. The AD amyloid cascade hypothesis proposes that Aβ production or reduced clearance leads to toxicity. In contrast, the cholinergic hypothesis argues for a specific pathology of brain cholinergic pathways. However, neither hypothesis in isolation explains the pattern of AD pathogenesis. Evidence suggests that a connection exists between these two scenarios: the synaptic form of human acetylcholinesterase (hAChE-S) associates with plaques in AD brains; among hAChE variants, only hAChE-S enhances Aβ fibrillization in vitro and Aβ deposition and toxicity in vivo Only hAChE-S contains an amphiphilic C-terminal domain (T40, AChE575-614), with AChE586-599 homologous to Aβ and forming amyloid fibrils, which implicates T40 in AD pathology. We previously showed that the amyloid scavenger, insulin-degrading enzyme (IDE), generates T40-derived amyloidogenic species that, as a peptide mixture, seed Aβ fibrillization. Here, we characterized 11 peptides from a T40-IDE digest for β-sheet conformation, surfactant activity, fibrillization, and seeding capability. We identified residues important for amyloidogenicity and raised polyclonal antibodies against the most amyloidogenic peptide. These new antisera, alongside other specific antibodies, labeled sections from control, hAChE-S, hAPPswe, and hAChE-S/hAPPswe transgenic mice. We observed that hAChE-S β-sheet species co-localized with Aβ in mature plaque cores, surrounded by hAChE-S α-helical species. This observation provides the first in vivo evidence of the conformation of hAChE-S species within plaques. Our results may explain the role of hAChE-S in Aβ deposition and aggregation, as amyloidogenic hAChE-S β-sheet species might seed Aβ aggregation.
Highlights
Many neurodegenerative diseases are characterized by amyloid deposition
Evidence suggests that a connection exists between these two scenarios: the synaptic form of human acetylcholinesterase associates with plaques in Alzheimer’s disease (AD) brains; among hAChE variants, only hAChE-S enhances A fibrillization in vitro and A deposition and toxicity in vivo
We previously showed that the amyloid scavenger, insulin-degrading enzyme (IDE), generates T40-derived amyloidogenic species that, as a peptide mixture, seed A fibrillization
Summary
In vivo localization of human acetylcholinesterase-derived species in a -sheet conformation at the core of senile plaques in Alzheimer’s disease. The spread of senile plaque-containing hAChE-S beyond brain areas rich in cholintrary unit; hAChE-S, synaptic form of the human acetylcholinesterase; HHI, hydrophobic– hydrophilic interface; HRP, horseradish peroxidase; IDE, insulin-degrading enzyme; KLH, keyhole limpet hemocyanin; Mab, monoclonal antibody; ThS, thioflavin S; ThT, thioflavin T; DAB, 3,3Ј-diaminobenzidine; NFT, neurofibrillary tangle; h, human. These findings provide the first in vivo evidence of hAChE-S conformation in senile plaques
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.